13.82
Benitec Biopharma Inc stock is traded at $13.82, with a volume of 22,079.
It is down -1.25% in the last 24 hours and up +19.96% over the past month.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
See More
Previous Close:
$14.00
Open:
$14.06
24h Volume:
22,079
Relative Volume:
0.20
Market Cap:
$362.91M
Revenue:
$59,000
Net Income/Loss:
$-21.81M
P/E Ratio:
-1.2623
EPS:
-10.9518
Net Cash Flow:
$-18.07M
1W Performance:
+4.42%
1M Performance:
+19.96%
6M Performance:
+13.32%
1Y Performance:
+55.77%
Benitec Biopharma Inc Stock (BNTC) Company Profile
Name
Benitec Biopharma Inc
Sector
Industry
Phone
(510) 780-0819
Address
3940 TRUST WAY, HAYWARD, CA
Compare BNTC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BNTC
Benitec Biopharma Inc
|
13.82 | 367.51M | 59,000 | -21.81M | -18.07M | -10.95 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.11 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.89 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
571.39 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
749.98 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
340.90 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-07-25 | Initiated | TD Cowen | Buy |
Dec-16-24 | Initiated | H.C. Wainwright | Buy |
Dec-13-24 | Initiated | Robert W. Baird | Outperform |
Oct-16-24 | Initiated | Oppenheimer | Outperform |
Sep-12-24 | Initiated | Guggenheim | Buy |
Jul-22-24 | Initiated | Leerink Partners | Outperform |
Jun-13-24 | Initiated | Piper Sandler | Overweight |
Oct-05-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Apr-20-20 | Initiated | Ladenburg Thalmann | Buy |
Feb-26-16 | Downgrade | Maxim Group | Buy → Hold |
Dec-31-15 | Reiterated | Maxim Group | Buy |
Sep-16-15 | Reiterated | Maxim Group | Buy |
View All
Benitec Biopharma Inc Stock (BNTC) Latest News
Can Benitec Biopharma Inc. hit a new high this monthTrade Exit Summary & High Accuracy Trade Alerts - Newser
Volatility clustering patterns for Benitec Biopharma Inc.2025 Volume Leaders & AI Forecasted Entry and Exit Points - Newser
Real time scanner hits for Benitec Biopharma Inc. explainedJobs Report & Weekly High Potential Stock Alerts - Newser
Applying chart zones and confluence areas to Benitec Biopharma Inc.Market Risk Report & Low Risk High Win Rate Stock Picks - Newser
Is Benitec Biopharma Inc. in a long term uptrend2025 Momentum Check & Short-Term Swing Trade Alerts - khodrobank.com
Sector ETF performance correlation with Benitec Biopharma Inc.Portfolio Value Summary & AI Forecasted Stock Moves - Newser
What’s the RSI of Benitec Biopharma Inc. stockWeekly Market Report & Target Return Focused Picks - khodrobank.com
Is Benitec Biopharma Inc. building a consolidation baseJuly 2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
Benitec Biopharma Inc. stock daily chart insightsJuly 2025 Volume & Fast Gain Swing Trade Alerts - Newser
Short interest data insights for Benitec Biopharma Inc.Quarterly Portfolio Report & AI Forecast for Swing Trade Picks - Newser
Visual trend scoring systems applied to Benitec Biopharma Inc.Options Play & Risk Controlled Stock Pick Alerts - Newser
Is it time to cut losses on Benitec Biopharma Inc.2025 Price Action Summary & Intraday High Probability Setup Alerts - Newser
Tick level data insight on Benitec Biopharma Inc. volatilityQuarterly Profit Report & AI Driven Price Forecasts - Newser
Benitec Biopharma Inc. stock momentum explainedMarket Performance Summary & Fast Entry Momentum Alerts - Newser
Is Benitec Biopharma Inc.’s ROE strong enough2025 EndofYear Setup & Fast Gain Swing Alerts - khodrobank.com
What momentum shifts mean for Benitec Biopharma Inc.Sell Signal & High Return Stock Watch Alerts - Newser
Detecting price anomalies in Benitec Biopharma Inc. with AIMarket Performance Recap & AI Driven Stock Price Forecasts - Newser
Benitec Biopharma Inc. stock chart pattern explained2025 Valuation Update & Safe Capital Growth Tips - Newser
Candlestick signals on Benitec Biopharma Inc. stock todayJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser
What candlestick patterns are forming on Benitec Biopharma Inc.Gap Up & Breakout Confirmation Trade Signals - Newser
What is Benitec Biopharma Inc. s debt to equity ratio2025 Major Catalysts & Intraday High Probability Setup Alerts - khodrobank.com
Does Benitec Biopharma Inc. have consistent dividend growthGDP Growth & Momentum Based Trading Ideas - khodrobank.com
Applying Elliott Wave Theory to Benitec Biopharma Inc.July 2025 Recap & Free Technical Pattern Based Buy Signals - Newser
What’s the profit margin of Benitec Biopharma Inc.2025 EndofYear Setup & Free Community Consensus Stock Picks - khodrobank.com
Can Benitec Biopharma Inc. navigate macro headwinds2025 Geopolitical Influence & AI Driven Price Forecasts - khodrobank.com
Does Benitec Biopharma Inc. outperform in volatile marketsTrade Risk Assessment & Risk Managed Investment Signals - khodrobank.com
Is Benitec Biopharma Inc. stock suitable for long term investingJuly 2025 Gainers & Safe Entry Momentum Stock Tips - khodrobank.com
Retail Surge: Should I buy Benitec Biopharma Inc. stock nowJuly 2025 Retail & Weekly Return Optimization Alerts - khodrobank.com
Developing predictive dashboards with Benitec Biopharma Inc. dataEarnings Growth Report & Entry Point Confirmation Alerts - Newser
Published on: 2025-08-31 14:05:26 - Newser
Heatmap Data Shows High Activity in Benitec Biopharma Inc. Sector getLinesFromResByArray error: size == 0 - classian.co.kr
Is this a good reentry point in Benitec Biopharma Inc.Global Markets & Risk Adjusted Swing Trade Ideas - Newser
Benitec Biopharma Inc. Could See a Relief Rally From Support2025 Fundamental Recap & Risk Managed Investment Strategies - beatles.ru
Using data filters to optimize entry into Benitec Biopharma Inc.Market Activity Summary & Technical Entry and Exit Alerts - Newser
Order flow analysis tools used on Benitec Biopharma Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - Newser
Published on: 2025-08-30 21:47:04 - Newser
Fibonacci Retracement Aligns with Support in Benitec Biopharma Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Benitec Biopharma Inc Stock (BNTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Benitec Biopharma Inc Stock (BNTC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '24 |
Buy |
10.98 |
27,502 |
301,972 |
7,981,725 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 03 '24 |
Buy |
9.60 |
42,000 |
403,200 |
7,957,365 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):